Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled
Susan B. Anthony Pro-Life America opposed Heidi Overton's FDA confirmation until the Trump administration committed to ending mail-order abortion drugs.

TL;DR
- A pro-life group asked the Senate to delay Heidi Overton's FDA nomination until the Trump administration committed to ending mail-order abortion drugs.
- The group also wants the FDA to change how it studies the safety of abortion pills, citing flaws in the current methodology.
- The White House withdrew Overton's nomination due to a lack of Senate support.
- Senator Bill Cassidy stated he believed Overton had sufficient votes for confirmation.
- The pro-life group asserts the administration can implement policy changes immediately without an appointed FDA commissioner.